Hypha Labs, Inc.

Hypha Labs, Inc. was incorporated in Nevada on October 5, 2010. Until February 20, 2024, Hypha Labs operated as a service-oriented independent testing laboratory, data analytics, and media firm. It focused on the developing cannabis and hemp markets, supporting best practices for reliable testing and providing pharmaceutical-grade analysis under ISO-17025:2017 guidelines. The company operated a cannabis-testing lab in Nevada since 2015. On February 20, 2024, Hypha Labs completed the sale of the net assets of its wholly owned subsidiary, Digipath Labs, Inc., and ceased its operations in cannabis and hemp market testing, data analytics, and media. Following this asset sale, the company changed its name from Digipath, Inc. to Hypha Labs, Inc. On April 18, 2024, Hypha Products Inc., a wholly owned subsidiary, was formed to research, develop, and commercialize the Hypha Micropearl accelerator. This home appliance is designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The device, along with its replacement cartridges, produces enriched mycelium of functional mushrooms, called Micropearls, in eight days. These Micropearls contain active mushroom ingredients in a concentrated, tasteless, and odorless form that can be incorporated into food and beverages without altering flavor. The Hypha Micropearl accelerator is sold with pre-sterilized, ready-to-insert replacement cartridges containing nutrient formulations for Micropearl production.